|
PDHX expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.74140000051149E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.33279999999336E-05 |
| Normal-vs-Stage2 |
2.971400E-01 |
| Normal-vs-Stage3 |
1.82219999977917E-07 |
| Normal-vs-Stage4 |
3.00559999111272E-09 |
| Stage1-vs-Stage2 |
1.493180E-01 |
| Stage1-vs-Stage3 |
4.244400E-02 |
| Stage1-vs-Stage4 |
1.335540E-03 |
| Stage2-vs-Stage3 |
1.715690E-02 |
| Stage2-vs-Stage4 |
2.483100E-03 |
| Stage3-vs-Stage4 |
2.449800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.58820000051696E-07 |
| Normal-vs-AfricanAmerican |
3.578200E-03 |
| Normal-vs-Asian |
1.98641999999971E-05 |
| Caucasian-vs-AfricanAmerican |
7.479200E-01 |
| Caucasian-vs-Asian |
7.050800E-01 |
| AfricanAmerican-vs-Asian |
5.874000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.89980000001133E-06 |
| Normal-vs-Female |
3.07070000005183E-06 |
| Male-vs-Female |
3.360600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.041800E-04 |
| Normal-vs-Age(41-60Yrs) |
2.75999999965748E-07 |
| Normal-vs-Age(61-80Yrs) |
3.194800E-04 |
| Normal-vs-Age(81-100Yrs) |
1.122130E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.112300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.679000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.820190E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.776400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.941200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.415200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.070800E-01 |
| Classical-VS-Follicular |
7.670100E-02 |
| Classical-VS-Other |
7.432400E-01 |
| Classical-VS-Normal |
3.53600000002618E-06 |
| Tall-VS-Follicular |
1.280110E-02 |
| Tall-VS-Other |
7.070200E-01 |
| Tall-VS-Normal |
1.51746000000008E-05 |
| Follicular-VS-Other |
1.647250E-01 |
| Follicular-VS-Normal |
6.476300E-02 |
| Other-VS-Normal |
2.163900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.46280000001831E-06 |
| Normal-vs-N1 |
2.06670000002518E-06 |
| N0-vs-N1 |
2.600600E-01 |
|
|
